Maintaining the biologics supply chain in challenging times
As we all adjust to the progressive impact of Covid-19, one consequence has been an increased focus on the biologics supply chain. In such a dynamic and challenging environment, many BioPhorum members are actively engage...
Targeting ‘right first time’ with the new In-silico Strategies Workstream
In-silico modeling is an exciting, new area for many biomanufacturers as it creates the opportunity to reduce wasted exp...
How industry is using technology during the COVID-19 pandemic
The use of technology in its many forms was a recurring theme in BioPhorum’s recent COVID-19 Workforce Protection Surv...
New risk-based deviation management system can save members an average of 22,200 hours per site
Under a traditional deviation management system (DMS), all events are considered equal and usually require a 30-day clos...
How to assess EHS risks for commercial-scale CGT manufacture
The rapidly expanding field of cell and gene therapies (CGT) has the potential to revolutionize curative treatments....
Best practice forecasting – a new tool to enable a dialog on demand planning
When biomanufacturers and their suppliers discuss future demand for materials, a robust forecast is crucial to provide a...
Connected data, cobots and smart scientists: how to create the lab of the future
Many will recognize that the biopharmaceutical quality control (QC) laboratories need much more digital enablement to al...
BioPhorum strengthens supply chain resilience through digitization of the supply chain and alternatives to gamma sterilization
Since 2016, BioPhorum Supply Partner has made great progress in bringing together manufacturers and supply partners to b...
PUPSIT: identifying risks and preventive controls
Pre-use post-sterilization integrity testing (PUPSIT) continues to generate considerable debate in the industry. Committ...
A clear path to implementing alternative and rapid microbiological methods
Several alternative and rapid microbiological methods (ARMM) are now available to detect and enumerate microbiological c...
How to solve the CCI puzzle
Container–closure integrity (CCI) is a vital patient-safety and product-efficacy aspect of parenteral biopharmaceutica...
Survey sheds light on plug-and-play use
Automation is often on the critical path for facility build and reconfiguration projects. It has many benefits – such ...
How is industry responding to the covid-19 pandemic?
During the covid-19 pandemic, it is even more important that we connect, share information and help each other meet the ...
